Jan 06, 2022 / 02:00PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Good morning, everyone, and good afternoon. I'm Matt Sykes, the senior life science tools and diagnostics analyst at Goldman Sachs. And we have the pleasure today of hosting Marc Casper, the Chairman, President and CEO of Thermo Fisher. Marc, Happy New Year, and thanks for joining.
Marc N. Casper - Thermo Fisher Scientific Inc. - Chairman, President & CEO
Matt, happy New Year, and thanks for having me. It's great to be with you today, albeit virtually.
Questions and Answers:
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research AnalystGreat. Well, I thought I'd let set the stage for us for the first few minutes. You hosted your Investor Day in September where you upgraded your long-term growth guidance and then reported strong numbers in Q3. Perhaps you can share a bit on the -- a bit of the trends that you've been seeing within your end markets, and what has changed, if anything, over the
Trustpilot
